This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Growth and Weight Gain in ELBW Infants Fed an Exclusively Human Milk Based Diet With Prolacta®

Sponsored by Medical University of Vienna

About this trial

Last updated 6 years ago

Study ID

Prolacta

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
1 to 8 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 7 years ago

What is this trial about?

Preterm infants are susceptible to postnatal growth restriction. Breast milk is the recommended source of nutrition for preterm infants. As preterm infants have enhanced nutritional requirements, multicomponent fortifiers are added to breast milk in order to establish adequate growth. Due to the various benefits of human milk feds to preterm infants, a human milk fortifier based on donor milk (Prolact+6 H2MF® Prolacta, City of Industry, California) has been developed. With this study, the investigators want to evaluate the effect of human milk fortification on weight gain in extremely low birth weight infants (ELBW, <1000g birth weight) in comparison to bovine fortification.

What are the participation requirements?

Yes

Inclusion Criteria

- Preterm infants with a birth weight <1000 g

No

Exclusion Criteria

- Congenital heart disease

- Major congenital birth defects

- Major inborn error of metabolism

Locations

Location

Status